Ethyl lauroyl arginate hydrochloride: Why SCCS and EFSA Safety Records Diverge

Ethyl lauroyl arginate hydrochloride is flagged in the cross-vertical regulatory-gap output because the same CAS record (60372-77-2) has different no-observed values in SCCS-family and EFSA source records. The lead row compares rat oral data in mg/kg bw/day.

What Each Source Says

The EFSA-side value in the lead row is 47 mg/kg bw/day. The SCCS-family value in the same matched comparison is 271 mg/kg bw/day. The finding states that the EFSA no-observed value is lower than the SCCS-family no-observed value for the same CAS, species, route, and unit.

That match condition is important. This is not a broad statement that every safety endpoint for Ethyl lauroyl arginate hydrochloride disagrees. The finding is narrower and stronger: the comparison holds within the normalized species, route, and unit keys shown in the table.

Why It Matters for Formulators

For cosmetic formulation, the SCCS-family record is the more directly cosmetic source. EFSA data, however, can still matter when the same chemical identity appears across food, pesticide, or other exposure contexts. A lower EFSA no-observed value does not automatically rewrite a cosmetic opinion, but it does mark a substance that deserves careful source-by-source review.

The practical takeaway is to avoid collapsing all NOAEL values for Ethyl lauroyl arginate hydrochloride into a single number. The source corpus, study type, species, route, and endpoint context all carry weight. A one-number summary would hide the divergence that makes this substance worth checking.

What Not to Infer

This divergence row is not a standalone ban, approval, or reformulation deadline. It is a source-comparison signal. The correct inference is narrower: for Ethyl lauroyl arginate hydrochloride, one matched EFSA no-observed value is lower than one or more matched SCCS-family values under the same normalized comparison keys. That is enough to justify review, but not enough to replace the underlying source documents.

The page is therefore useful as a map, not a verdict. It points to the precise mismatch a reviewer should investigate: chemical identity, endpoint value, route, species, unit, and source corpus. Those details are the difference between a real regulatory divergence story and a vague claim that two authorities disagree.

If a brand is using Ethyl lauroyl arginate hydrochloride globally, this kind of cross-source mismatch is where review time should go first. A single cosmetic formulation may be legal and still deserve a closer toxicology note when another major source corpus reports a lower point of departure for a matched comparison.

The safest editorial wording is therefore specific: this page compares records, not countries. The source labels, values, and normalized matching keys are shown so the claim stays tied to the evidence that created the divergence flag.

Next Read

Use the Ethyl lauroyl arginate hydrochloride ingredient page for substance identity and cross-source profile, then trace the SCCS or EFSA source records listed below for the exact study-level wording.

Source

• Cross-vertical finding: query1_regulatory_gaps.json
• src_corpus: EFSA; source: EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx; src_file: Source documentation archived. reference: EFSA AFC - 2007 - OutputID 297 - clinical chemistry - immunotoxicity - Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission.
• src_corpus: SCCS; source: SCCS_vision_codex; src_file: sccp_o_129.pdf; reference: {"dose":"SCCP/1106/07 Opinion on ethyl lauroyl arginate HCl 55 The NOAEL derived from the chronic toxicity study (52 week, oral, rat) for ethyl lauroyl arginate of 271 mg/kg bw/day was used.","effect":"SCCP/1106/07 Opin.